Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.93 Billion EUR | 117.63% |
| 2022 | 3.21 Billion EUR | -17.92% |
| 2021 | 3.41 Billion EUR | -16.85% |
| 2020 | 3.83 Billion EUR | 0.52% |
| 2019 | 3.78 Billion EUR | -25.73% |
| 2018 | 3.73 Billion EUR | -1.27% |
| 2017 | 3.06 Billion EUR | -4.53% |
| 2016 | 3.05 Billion EUR | 13.79% |
| 2015 | 2.88 Billion EUR | 15.77% |
| 2014 | 2.41 Billion EUR | 17.55% |
| 2013 | 2.12 Billion EUR | -0.7% |
| 2012 | 2.31 Billion EUR | 3.03% |
| 2011 | 2.07 Billion EUR | 12.63% |
| 2010 | 1.84 Billion EUR | 18.26% |
| 2009 | 1.55 Billion EUR | 2.73% |
| 2008 | 1.51 Billion EUR | 13.87% |
| 2007 | 1.35 Billion EUR | 10.88% |
| 2006 | 1.24 Billion EUR | 19.61% |
| 2005 | 1 Billion EUR | 25.58% |
| 2004 | 800.33 Million EUR | 3.5% |
| 2003 | 773.23 Million EUR | -10.39% |
| 2002 | 862.93 Million EUR | -20.09% |
| 2001 | 789.79 Million EUR | 7.49% |
| 2000 | 1 Billion EUR | -30.06% |
| 1999 | 839.17 Million EUR | 91.35% |
| 1998 | 654.81 Million EUR | -74.65% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 987.35 Million EUR | -25.62% |
| 2024 Q3 | 804 Million EUR | 1.3% |
| 2024 Q2 | 736.45 Million EUR | 27.89% |
| 2023 Q4 | 880.44 Million EUR | 9.59% |
| 2023 Q2 | 863.63 Million EUR | 19.95% |
| 2023 Q3 | 803.4 Million EUR | -6.97% |
| 2023 Q1 | 720 Million EUR | 90.98% |
| 2023 FY | - EUR | 117.63% |
| 2022 Q1 | 780.73 Million EUR | 63.68% |
| 2022 FY | - EUR | -17.92% |
| 2022 Q2 | 776 Million EUR | -0.61% |
| 2022 Q4 | 377 Million EUR | -61.91% |
| 2022 Q3 | 989.67 Million EUR | 27.53% |
| 2021 Q1 | 877.71 Million EUR | 84.01% |
| 2021 Q2 | 833.71 Million EUR | -5.01% |
| 2021 Q3 | 923.08 Million EUR | 10.72% |
| 2021 Q4 | 477 Million EUR | -48.33% |
| 2021 FY | - EUR | -16.85% |
| 2020 Q4 | 477 Million EUR | -53.65% |
| 2020 Q1 | 940.23 Million EUR | 52.64% |
| 2020 Q2 | 1.06 Billion EUR | 12.87% |
| 2020 Q3 | 1.02 Billion EUR | -3.03% |
| 2020 FY | - EUR | 0.52% |
| 2019 Q2 | 896.85 Million EUR | -3.24% |
| 2019 Q4 | 616 Million EUR | -39.78% |
| 2019 Q3 | 1.02 Billion EUR | 14.06% |
| 2019 FY | - EUR | -25.73% |
| 2019 Q1 | 926.87 Million EUR | -1.5% |
| 2018 Q3 | 705.69 Million EUR | -5.68% |
| 2018 Q2 | 748.17 Million EUR | 7.5% |
| 2018 Q1 | 696 Million EUR | -1.83% |
| 2018 Q4 | 941 Million EUR | 33.34% |
| 2018 FY | - EUR | -1.27% |
| 2017 Q3 | 798.74 Million EUR | 3.83% |
| 2017 FY | - EUR | -4.53% |
| 2017 Q4 | 709 Million EUR | -11.24% |
| 2017 Q2 | 769.3 Million EUR | -11.56% |
| 2017 Q1 | 869.87 Million EUR | -8.33% |
| 2016 Q1 | 646.9 Million EUR | -19.63% |
| 2016 Q4 | 948.93 Million EUR | 21.93% |
| 2016 Q3 | 778.29 Million EUR | 1.13% |
| 2016 Q2 | 769.62 Million EUR | 18.97% |
| 2016 FY | - EUR | 13.79% |
| 2015 Q3 | 709.84 Million EUR | 8.35% |
| 2015 FY | - EUR | 15.77% |
| 2015 Q2 | 655.14 Million EUR | -4.15% |
| 2015 Q1 | 683.51 Million EUR | -6.92% |
| 2015 Q4 | 804.9 Million EUR | 13.39% |
| 2014 Q1 | 456.23 Million EUR | -20.69% |
| 2014 Q4 | 734.36 Million EUR | 15.99% |
| 2014 FY | - EUR | 17.55% |
| 2014 Q2 | 541.85 Million EUR | 18.77% |
| 2014 Q3 | 633.12 Million EUR | 16.85% |
| 2013 Q2 | 537.64 Million EUR | 4.45% |
| 2013 Q1 | 514.74 Million EUR | 1.66% |
| 2013 FY | - EUR | -0.7% |
| 2013 Q4 | 575.24 Million EUR | 8.12% |
| 2013 Q3 | 532.05 Million EUR | -1.04% |
| 2012 Q4 | 506.33 Million EUR | 13.11% |
| 2012 FY | - EUR | 3.03% |
| 2012 Q1 | 488.63 Million EUR | -23.36% |
| 2012 Q2 | 577.41 Million EUR | 18.17% |
| 2012 Q3 | 447.65 Million EUR | -22.47% |
| 2011 FY | - EUR | 12.63% |
| 2011 Q4 | 637.6 Million EUR | 23.19% |
| 2011 Q3 | 517.55 Million EUR | 15.43% |
| 2011 Q2 | 448.35 Million EUR | 8.41% |
| 2011 Q1 | 413.55 Million EUR | -23.83% |
| 2010 Q3 | 435.03 Million EUR | -12.43% |
| 2010 Q1 | 412.5 Million EUR | -9.52% |
| 2010 Q2 | 496.77 Million EUR | 20.43% |
| 2010 FY | - EUR | 18.26% |
| 2010 Q4 | 542.9 Million EUR | 24.8% |
| 2009 Q2 | 377.64 Million EUR | -0.9% |
| 2009 Q3 | 385.7 Million EUR | 2.13% |
| 2009 Q4 | 455.91 Million EUR | 18.2% |
| 2009 FY | - EUR | 2.73% |
| 2009 Q1 | 381.08 Million EUR | -9.43% |
| 2008 Q2 | 337.82 Million EUR | 9.94% |
| 2008 FY | - EUR | 13.87% |
| 2008 Q4 | 420.78 Million EUR | 7.71% |
| 2008 Q3 | 390.65 Million EUR | 15.64% |
| 2008 Q1 | 307.28 Million EUR | -10.48% |
| 2007 Q3 | 334.15 Million EUR | -4.88% |
| 2007 Q2 | 351.28 Million EUR | 4.38% |
| 2007 FY | - EUR | 10.88% |
| 2007 Q1 | 336.55 Million EUR | 12.34% |
| 2007 Q4 | 343.24 Million EUR | 2.72% |
| 2006 Q2 | 321.11 Million EUR | 27.68% |
| 2006 Q4 | 299.57 Million EUR | -11.16% |
| 2006 FY | - EUR | 19.61% |
| 2006 Q3 | 337.2 Million EUR | 5.01% |
| 2006 Q1 | 251.5 Million EUR | -8.53% |
| 2005 FY | - EUR | 25.58% |
| 2005 Q4 | 274.95 Million EUR | 10.37% |
| 2005 Q3 | 249.11 Million EUR | -0.67% |
| 2005 Q2 | 250.8 Million EUR | 16.24% |
| 2005 Q1 | 215.76 Million EUR | 34.88% |
| 2004 FY | - EUR | 3.5% |
| 2004 Q4 | 159.97 Million EUR | -26.15% |
| 2004 Q2 | 221.54 Million EUR | 7.03% |
| 2004 Q3 | 216.62 Million EUR | -2.22% |
| 2004 Q1 | 206.99 Million EUR | 25.26% |
| 2003 Q2 | 202.66 Million EUR | -0.11% |
| 2003 Q1 | 202.88 Million EUR | 10.52% |
| 2003 FY | - EUR | -10.39% |
| 2003 Q4 | 165.25 Million EUR | -22.85% |
| 2003 Q3 | 214.18 Million EUR | 5.68% |
| 2002 Q2 | 218.67 Million EUR | -15.26% |
| 2002 Q3 | 225.01 Million EUR | 2.9% |
| 2002 Q4 | 183.57 Million EUR | -18.42% |
| 2002 FY | - EUR | -20.09% |
| 2002 Q1 | 258.05 Million EUR | 2728.74% |
| 2001 FY | - EUR | 7.49% |
| 2001 Q4 | -9.81 Million EUR | -103.84% |
| 2001 Q3 | 255.45 Million EUR | -13.09% |
| 2001 Q2 | 293.93 Million EUR | 8.79% |
| 2001 Q1 | 182.79 Million EUR | 37.58% |
| 2000 FY | - EUR | -30.06% |
| 2000 Q4 | 196.37 Million EUR | -54.93% |
| 2000 Q3 | 435.72 Million EUR | 167.67% |
| 2000 Q2 | 162.78 Million EUR | -27.99% |
| 2000 Q1 | 226.05 Million EUR | 110.58% |
| 1999 Q1 | 891.88 Million EUR | 150.23% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 Q4 | -2.13 Billion EUR | -338.0% |
| 1999 FY | - EUR | 91.35% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | - EUR | -74.65% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q4 | -1.77 Billion EUR | -335.05% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | - EUR | 0.0% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 2.73 Billion EUR | -7.271% |
| LIMES Schlosskliniken AG | 854.98 Thousand EUR | -343048.912% |
| M1 Kliniken AG | 21.79 Million EUR | -13362.577% |
| Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -62123.924% |
| MEDICLIN Aktiengesellschaft | 101.26 Million EUR | -2797.226% |
| RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | -2416.562% |
| VITA 34 AG | 5.8 Million EUR | -50431.485% |